Day One Biopharmaceuticals Inc (DAWN)
US$ 7.22-6.36%
Price Chart
Key Statistics
Market Cap
$ 656.83M
P/E Ratio
0.00
Revenue (TTM)
$ 161.92M
Volume
920.37K
52W High
$ 16.76
52W Low
$ 6.08
Dividend Yield
0.00%
Beta
-1.24
Technicals
50-Day MA
7.4916
200-Day MA
11.8123
52 Week High
16.76
52 Week Low
6.08
About DAWN
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
Employees
181
Headquarters
Brisbane, CA
CEO
Dr. Jeremy Bender M.B.A., Ph.D.
Latest News
Deimos Before Dawn - NASA (.gov)
4 days ago • Google News
Dawn Richard Testifies Sean "Diddy" Combs Told Her She Could Die or "Go Missing" - E! Online
20 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg